July/August 2021 | Web Exclusive
Paralympic Swimmer with Stargardt Heads to Tokyo
Gia Pergolini refuses to let vision loss stop her from achieving her dream: competing in the 2020 Paralympics.
Rebecca Hepp, Editor-in-Chief
July/August 2021 | Medical Editors' Page
A Thirst for More
Robert L. Avery, MD, and Allen C. Ho, MD
July/August 2021 | Features
Let’s Talk About Gene Therapy for Inherited Retinal Diseases
The approval of the first gene therapy in the United States has sparked significant interest in this patient population. What’s next in the research pipeline?
Mark E. Pennesi, MD, PHD; Jacque L. Duncan, MD; Andreas Lauer, MD; Aaron Nagiel, MD, PhD; Artur V. Cideciyan, PHD; and Allen C. Ho, MD
July/August 2021 | Features
The Ins and Outs of Genetic Testing for Inherited Retinal Diseases
The more you know about a patient’s genetic status, the better equipped you are to recommend clinical trials.
Marc Mathias, MD
July/August 2021 | Features
AAV Gene Therapy Trials To Watch
Here’s what you need to know about the many gene therapies under investigation for inherited retinal diseases.
Christine Kay, MD
July/August 2021 | Features
Tips and Tricks for Evaluating Children for Inherited Retinal Degenerations
Novel therapeutics and those in the pipeline are changing how we care for patients with IRDs. Here’s what you need to know.
David Xu, MD; Michael N. Cohen, MD; Michael A. Klufas, MD; and Jose S. Pulido, MD, MS, MBA, MPH
July/August 2021 | Features
Localized Steroid Therapy for Chronic Noninfectious Posterior Uveitis
A review of recent literature and an illustrative case highlight the pros and cons of this treatment option.
Sumit Sharma, MD
July/August 2021 | Features
Three Pearls for Surgery in Uveitis Patients
Addressing these important questions can help to ensure a positive outcome.
Lisa J. Faia, MD
July/August 2021 | Meeting Minutes
Angiogenesis, Exudation, and Degeneration 2021—Virtual Edition
New findings around iRORA and cRORA.
David Sarraf, MD; Philip J Rosenfeld, MD; and Matthew R. Starr, MD
July/August 2021 | Imaging
Clinical Utility of OCT Angiography for AMD
In part 1 of this two-part series, the authors explore the advantages and disadvantages of this imaging modality.
Koosha Ramezani, MD; Hagar Khalid, MD; Luísa S.M. Mendonça, MD; and Nadia K. Waheed, MD, MPH
July/August 2021 | Global Perspectives
Valsalva Retinopathy and Crossfit Training
When and how to treat this rare entity in young, active people.
Pedro Manuel Baptista, MD; Catarina Castro, MD; André Ferreira, MD; João Leite, MD; Pedro Menéres, MD; and Angelina Meireles, MD
July/August 2021 | Surgical Pearls
14 Tips for Scleral Suturing For Any IOL
A good technique for repositioning a dislocated lens can be adapted to many designs.
William E. Smiddy, MD
July/August 2021 | Medical Retina
A Rare Manifestation of Chronic Myelogenous Leukemia
This condition should remain in the differential when a patient presents with signs of ocular ischemic syndrome.
Michael Weaver, DO; Samir Dalia, MD; and Heeral R. Shah, MD
July/August 2021 | Ocular Oncology
Uveal Melanoma Classified by The Cancer Genome Atlas
This new system can help identify patients at high risk for metastasis, possibly paving the way for targeted adjuvant therapy.
Zeynep Bas, MD, and Carol L. Shields, MD
July/August 2021 | Coding Advisor
Action Steps to Effectively Manage Prior Authorization and Step Therapy Policies
The entire staff can contribute to reducing rejections.
Joy Woodke, COE, OCS, OCSR
July/August 2021 | Visually Speaking
Intravitreal Cysticercosis With Full Thickness Macular Hole
This rare presentation was managed with vitrectomy, membrane peeling, and excision of the cyst.
Vishal Agrawal, MD, FRCS
July/August 2021 | 5 Questions
5Q with Aaron Nagiel, MD, PHD
Aaron Nagiel, MD, PhD